Novartis CEO Says New Purchases Will Boost Sales

April 22 (Bloomberg) -- Novartis AG Chief Executive Officer Joe Jimenez talks about the agreement to buy GlaxoSmithKline Plc’s cancer-drug business for as much as $16 billion, forming a consumer-health venture with Glaxo and selling its animal-health operation to Eli Lilly & Co. for $5.4 billion. He speaks from Basel, Switzerland, with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)
European Shares, Euro Retreat on Greek News
35:10 - Bloomberg's Mark Barton and Julie Hyman report on today's action in the global markets. They speak on “Bloomberg Markets.” (Source: Bloomberg)
  • Iran Nuclear Deal Can Change Political Path: Walsh
  • Greece Won’t Make IMF Payment
  • Greece Staggers Into the Unknown: Surveillance (06/30)